Zymeworks Appoints Kristin Stafford as Chief Financial Officer
VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of...
Cancer
Cardiol Therapeutics Announces Year-End 2025 Update on Operations
Initiated pivotal Phase III MAVERIC trial of CardiolRx™ in recurrent pericarditis and surpassed 50% patient enrollment, with full enrollment expected...
Get Ready for RHTP: How Data-Driven Insights Can Help You Prepare
WATKINSVILLE, GA / ACCESS Newswire / March 31, 2026 / RHTPThe Rural Health Transformation Program (RHTP) is a monumental $50...
CollectiveMinds LLC Places Robert Hollingsworth, PhD as Chief Scientific Officer of Protillion Biosciences
Next-generation life sciences executive search firm supports venture-backed antibody discovery company in securing life-changing scientific leadershipHERNDON, Va., March 31, 2026...
Patriots QB Drake Maye, Wife Ann Michael and 800+ Granite Teammates Raise $4.155 Million for Boston Children’s Hospital
Granite's 'Saving by Shaving' Event Has Raised $62.7 Million for Health Care Since 2014QUINCY, Mass., March 31, 2026 /PRNewswire/ --...
Guardian completes integration with FINEOS to expand digital capabilities and deliver a simplified leave experience
New absence capabilities strengthen the company's ability to deliver a modern and connected leave experience for employees and the HR...
VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium
HENDERSON, Nev., March 31, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has secured an additional...
OpenProtein.AI Expands Strategic Partnership with Boehringer Ingelheim to Advance AI-Driven Antibody Discovery
Boehringer Ingelheim expands its collaboration with OpenProtein.AI following successful initial deployment, co-developing integrated workflows for next-generation therapeutic development.NEW YORK, March...
Plus Therapeutics Announces Reverse Stock Split
HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with...
Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
Expanding nucleic acid delivery business with new applicationsOngoing optimization of cost structureAdvancing plans for spin-off of nucleic acid delivery business...
Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod
SAN ANTONIO, TX / ACCESS Newswire / March 31, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC), a clinical-stage immunotherapeutics company,...
Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) in Advanced and Metastatic Triple-Negative Breast Cancer
First-in-class metal-modulating epigenetic therapy targeting iron-dependent pathways with preclinical efficacy and a favorable GLP safety profile. MIAMI, FL / ACCESS...
American Shared Hospital Services Reports Fourth Quarter and Full Year 2025 Financial Results
Announces Seven Year Extension of Proton Therapy Lease Agreement with Orlando Health Through 2033 Conference Call Scheduled for 12:00 PM...
Scott Vicknair Personal Injury Lawyers Supports Hogs for the Cause as Grand Champion Sponsor of Swine Krewe
NEW ORLEANS, March 30, 2026 /PRNewswire/ -- Scott Vicknair Personal Injury Lawyers is proud to announce its support of Hogs for...
Biointelli Launches Scientific Signal Intelligence™ — A New Category That Predicts Life Science Demand Before It Exists in Your CRM
CAMBRIDGE, Mass., March 30, 2026 /PRNewswire/ -- Biointelli Corporation today announced the launch of Biointelli Predict, the first commercial intelligence platform...
Centivax Closes $37 Million Financing to Accelerate Phase 2 Clinical Development of Universal Flu and Advance Follow-On Portfolio to Clinical Readiness
SOUTH SAN FRANCISCO, Calif., March 30, 2026 /PRNewswire/ -- Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for...
Abbott expands access to Precision Oncology portfolio through integration with Flatiron’s OncoEMR® platform
Broadens access to Abbott's Precision Oncology tests across more than 1,600 community cancer care centers and 4,700 providers in Flatiron's...
Atlantic Health Reduces Colonoscopy Screening Gaps Using Artera’s AI Agents
Pioneering Use of AI-Driven Outreach Helps Improve Screening for Colorectal Cancer, the Leading Cause of Death for Adults Under 50 1SANTA...
Tempest Reports Year End 2025 Financial Results and Provides Business Update
Completed strategic acquisition of dual-targeting CAR-T assets from Factor Bioscience Inc. Named Matt Angel, Ph.D., Chief Executive Officer & President...
Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones
– Full enrollment of BLA-enabling trial complete, per prior guidance –– Topline NEXICART-2 Results Expected Q3 2026, followed by BLA...